ARCHIVES

Nexavar Improves PFS In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Grants Up Fourfold Since 1970; Rappaport, Jensen Speakers At Annual AACR,ASCO Meeting

April 25, 1975

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

Dalton To Head Moffitt Cancer Center; HHS Appoints Gerberding CDC Director

July 12, 2002

Zerhouni Starts Work As NIH Director

May 24, 2002

In Surgery vs Radiotherapy, Outcome Differences Equalize After 15 Years Follow-up

February 22, 2013

NCAB Approves New Grant Award Honoring Howard Temin

March 8, 1996